Companies that report better-than-expected earnings typically see a positive short-term reaction in their stock price as investors adjust their expectations upwards. The direct mention of Verrica Pharmaceuticals' Q1 revenue outperformance is a strong indicator of positive sentiment and investor confidence, likely leading to a short-term uptick in VRCA's stock price.